Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Keywords
- Clinical Pharmacist
- Sequential Therapy
- Infectious Disease Society
- Infectious Disease Physician
- Infection Management
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Allen, B., Naismith, N. W., Manser, A. J., and Moulds, R. F. W., 1992, A campaign to improve timing of conversion from intravenous to oral administration of antibiotics. Aust. J. Hosp. Pharm., 12, 343–439.
American Society of Consultant Pharmacists, 1997, Guidelines on the Role of the Consultant Pharmacist in Infection Control in Long-term Care Facilities. www.ascp.com/public/pr/guide lines/infection.shtml
American Society of Hospital Pharmacists, 1993, ASHP technical assistance bulletin on the pharmacists’ role in immunization. Am. J. Hosp. Pharm., 50, 501–505.
American Society of Health-System Pharmacists, 1998, ASHP statement on the pharmacist’s role in infection control. Am. J. Health-Syst. Pharm., 55, 1724–1726.
Ariano, R. E., Demianczuk, R. H., Danzinger, R. G., Richard, A., Milan, H., and Jamieson, B., 1995, Economic impact and clinical benefits of pharmacist involvement on surgical wards. Can. J. Hosp. Pharm., 48, 284–289.
Audit Commission for Local Authorities and the National Health Service in England and Wales. A Spoonful of Sugar. Medicines management in NHS Hospitals. Audit Commissions Publications, December 2001. www.audit-commission.gov.uk/publications/spoonfulsugar.shtml.
Avorn, J. and Solomon, D. H., 2000, Cultural and economic factors that (mis)shape antibiotic use: The nonpharmacologic basis of therapeutics. Ann. Intern. Med., 133, 128–135.
Avorn, J. and Soumerai, J. A., 1983, Improving drug therapy decisions through educational outreach. A randomised trial of academically based “detailing.” N. Engl. J. Med., 308, 1457–1463.
Barenfanger, J., Short, M. A., and Groesch, A. A., 2001, Improved antimicrobial interventions have benefits. J. Clin. Microbiol., 39, 2823–2828.
Barriere, S. L., Dudley, M. N., Kowalsky, S. F., Kreter, B., Polk, R. E., Prince, R. A. et al., 1989, The role of the pharmacist in antimicrobial agent therapy. J. Infect. Dis., 159, 593–594.
Bedard, M. and McLean, W., 1994, A regional pharmacokinetic consultation service. Can. J. Hosp. Pharm., 47, 268–276.
Berman, J. R., Zaran, F. K., and Rybak, M. J., 1992, Pharmacy-based antimicrobial-monitoring service. Am. J. Hosp. Pharm., 49, 1701–1706.
Bosch, J., 2000, New role proposed for spanish pharmacists (Letter). Lancet, 356, 52.
Burke, J. P., 2001, Maximizing appropriate antibiotic prophylaxis for surgical patients: An update from LDS Hospital, Salt Lake City. Clin. Infect. Dis., 33(Suppl 2), S78–S83.
Burke, J. D., Ahkee, S., Ritter, G. W., and Ramirez, J. A., 1996, Development of an interdisciplinary antimicrobial team: Elements for success. Hosp. Pharm., 31, 361–366.
Cairns, C., 1998, Implementation of sequential therapy programmes—a pharmacist’s view. J. Infect., 37(Suppl 1), 55–59.
Chawla, P. and Slayter, K., 1996, Pharmacy initiated antibiotic streamlining. Can. J. Hosp. Pharm., 49, 128–129.
Cook, A. A. and Sanchez, M. L., 1992, A multidisciplinary process to determine, communicate, and manage an antibiotic formulary. Hosp. Pharm., 27, 867–869, 872–874, 882.
The Copenhagen Recommendations. Report from the Invitational EU Conference on the Microbial Threat. September 9–10, 1998, Copenhagen, Denmark.
Cradle, R. M., Darouiche, R. O., Tibbetts, C. S., and Graviss, E., 1995, Pharmacist’s impact on antimicrobial drug therapy. Am. J. Health-Syst. Pharm., 52, 1544–1546.
Davey, P., Brown, E., Hartman, G., and Ramsay, C., 2002, Room for improvement: Poor quality of evaluation of interventions for improving antibiotic prescribing to hospital inpatients. Poster presentation at 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 26–30, 2002, San Diego, USA.
Dean, B., Lawson, W., Jacklin, A., Rogers, T., Azadian, B., and Holmes, A., 2002a, The use of serial-point prevalence studies to investigate hospital anti-infective prescribing. Int. J. Pharm. Prac., 10, 121–125.
Dean, B., Schachter, M., Vincent, C., and Barber, N., 2002b, Causes of prescribing errors in hospital inpatients: A prospective study. Lancet., 359, 1373–1378.
Department of Health, March 1999, Health Services Circular 1999/049. Resistance to antibiotics and other antimicrobial agents. Crown Publishing.
Department of Health, July 2000, The NHS Plan; A plan for investment—A plan for reform. The Stationary Office. www.nhs.uk/nhsplan
Department of Health NHS Executive, June 2000, UK Antimicrobial Resistance Strategy and Action Plan. Crown Publishing. www.doh.gov.uk/arbstrat.htm
Dickerson, L. M., Mainous, A. G., and Carek, P. J., 2000, The pharmacist’s role in promoting optimal antimicrobial use. Pharmacotherapy, 20, 711–723.
Evans, R. S., Pestonik, S. L., Classen, D. C., Clemmer, T. P, Weaver, L. K., Orme, J. F. et al., 1998, A computer-assisted management program for antibiotics and other antiinfective agents. N. Engl. J. Med., 338, 232–238.
Feucht, C. L. and Rice, L. B., 2003, An interventional program to improve antibiotic use. Ann. Pharmacother., 37, 646–651.
Fletcher, C. V., Metzler, D., Borchardt-Phelps, P., and Rodman, J. H., 1990, Patterns of antibiotic use and expenditure during 7 years at a university hospital. Pharmacotherapy, 10, 199–204.
Fraser, G. L., Stogsdill, P., Dickens, J. D., Wennberg, D. E., Smith, R. P., and Prato, B. S., 1997, Antibiotic optimisation: An evaluation of patient safety and economic outcomes. Arch. Intern. Med., 157, 1689–1694.
Frighetto, L., Nickoloff, D., Martinusen, S. M., Mamdani, G. S., and Jewesson, P. J., 1992, Intravenous-to oral stepdown programme: Four years of experience in a large teaching hospital. Ann. Pharmacother., 26, 1447–1451.
Garey, K. W., Liang, P., Itokazu, G., Schwartz, D., Rydman, R., Danziger, L. H. et al., 2000, A North American (NA) survey of Infectious Diseases Pharmacists (IDP) perspectives on Antibiotic Control Programs (ACP). Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 17–20, 2000, Toronto, Canada.
Gentry, C. A., Greenfield, R. A., Slater, L. N., Wack, M., and Huycke, M. M., 2000, Outcomes of an antimicrobial control program in a teaching hospital. Am. J. Health-Syst. Pharm., 57, 268–274.
Goldmann, D. A., Weinstein, R. A., Wenzel, R. P., Tablan, O. C., Duma, R. J., Gaynes, R. P. et al., 1996, Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: A challenge to hospital leadership. J. A. M. A., 275, 234–240.
Gould, I. M. and Jappy, B., 2000, Antimicrobial practice. Trends in antimicrobial prescribing after 9 years of stewardship. J. Antimicrob. Chemother., 45, 913–917.
Grabenstein, J. D. and Bonasso, J., 1999, Health-system pharmacists’ role in immunizing adults against pneumococcal disease and influenza. Am. J. Health-Syst. Pharm., 56(17Suppl 2), S3–S22.
Grasela, T. H., Edwards, B. A., Raebel, M. A., Sisca, T. S., Zarowitz, B. J., and Schentag, J. J., 1987, A clinical pharmacy-oriented drug surveillance network: II. Results of a pilot project. DrugIntell. Clin. Pharm., 21, 909–914.
Grasela, T. H., Walawander, C. A., Kennedy, D. L., and Jolson, H. M., 1993, Capability of hospital computer systems in performing drug-use evaluations and adverse drug event monitoring. Am. J. Hosp. Pharm., 50, 1889–1895.
Gross, R., Morgan, A. S., Kinky, D. E., Weiner, M., Gibson, G. A., and Fishman, N. O., 2001, Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin. Infect. Dis., 33, 289–295.
Guglielmo, B. J., Lubner, A. D., Corelli, R. L., Flaherty, J. F., and Jacobs, R. A., 1999, Prevention of adverse events in hospitalised patients using an antimicrobial review program. West. J. Med., 171, 159–162.
Gums, J. G., Yancey, R. W., Hamilton, C. A., and Kubilis, P. S., 1999, A randomised, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy, 19(12), 1369–1377.
Hamilton-Miller, J. M., 1996, Switch therapy: The theory and practice of early change from parenteral to non-parenteral antibiotic administration. Clin. Microbiol. Infect., 2(1), 12–19.
Hayman, J. N. and Crane, V. S., 1993, Multidisciplinary task force for controlling drug expenses. Am. J. Hosp. Pharm., 50, 2343–2347.
Hirschman, S. Z., Meyers, B. R., Bradbury, K., Mehl, B., Gendelman, S., and Kimelblatt, B., 1988, Use of antimicrobial agents in a university teaching hospital. Evolution of a comprehensive control program. Arch. Int. Med., 148, 2001–2007.
House of Lords Select Committee on Science and Technology, 1997, Resistance to Antibiotics and Other Antimicrobial Agents. 7th Report. Session 1997–8. HM Stationary Office, London.
Ibrahim, K. H., Gunderson, B., and Rotschafer, J. C., 2001, Intensive care unit antimicrobial resistance and the role of the pharmacist. Crit. Care Med., 29(Suppl), N108–N133.
Infectious Diseases Society of America Position Statement, 1997, Hospital pharmacists and infectious diseases specialists. Clin. Infect. Dis., 25, 802.
Jarvis, W. R., 1996, Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: The complexity of the problem. Infect. Cont. Hosp. Epidemiol., 17, 490–495.
Jenney, A., O’Reilly, M., Meagher, D., and Corallo, C. E., 1999, Interventions of an antibiotic management team. Aust. J. Hosp. Pharm., 29, 36–39.
Knox, K. L. and Holmes, A. H., 2002, Regulation of antimicrobial prescribing practices—a strategy for controlling nosocomial antimicrobial resistance. Int. J. Infect. Dis., 6(Suppl 1), S8–S13.
Kuti, J. L., Le, T. N., Nightingale, C. H., Nicolau, D. P., and Quintilliani, R., 2002, Pharmacoeconomics of a pharmacist managed program for automatically converting levo-floxacin route from i.v. to oral. Am. J. Health-Syst. Pharm., 59, 2209–2215.
Lawson, W., Ridge, K., Jacklin, A., and Holmes, A., 2000, Infectious diseases pharmacists in the UK: Promoting their role and establishing a national network. J. Infect., 40, A31.
Lee, J., Carlson, J. A., and Chamberlain, M. A., 1995, A team approach to hospital formulary replacement. Diagn. Microbiol. Infect. Dis., 22, 239–242.
Lelekis, M. and Gould, I. M., 2001, Sequential therapy for cost containment in the hospital setting: Why not? J. Hosp. Infect., 48, 249–257.
Lesar, T. S., Briceland, L., and Stein, D. S., 1997, Factors related to errors in medication prescribing. J. A. M. A., 277, 312–317.
Lipsky, B. A., Baker, C. A., McDonald, L. L., and Suzuki, N. T., 1999, Improving the appropriateness of vancomycin use by sequential interventions. Am. J. Infect. Control, 27, 84–90.
Lynch, T. J., Possidente, C. J., Cioffi, W. G., and Hebert, J. C., 1992, Multidisciplinary protocol for determining aminoglycoside dosage. Am. J. Hosp. Pharm., 49, 109–115.
Marr, J. J., Moffet, H. L., and Kunin, C. M., 1988, Guidelines for improving the use of antimicrobial agents in hospitals: A statement by the Infectious Diseases Society of America. J. Infect. Dis., 157, 869–876.
McMullin, S. T., Hennenfent, J. A., Ritchie, D. J., Huey, W. Y., Lonergan, T. P., Schaiff, R. A. et al., 1999, A prospective, randomised trial to assess the cost impact of pharmacist-initiated interventions. Arch. Intern. Med., 159, 2306–2309.
Minooee, A. and Rickman, L. S., 2000, Expanding the role of the infection control professional in the cost-effective use of antibiotics. Am. J. Infect. Control, 28, 57–65.
Nathwani, D. and Conlon, C., on behalf of the OHPAT Workshop, 1998. Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: A consensus statement by a working party. Clin. Microbiol. Infect., 4, 537–551.
Nathwani, D., Gray, K., and Borland, H., 2002, Quality indicators for antibiotic control programmes. J. Hosp. Infect., 50, 165–169. doi:10.1053/jhin.2001.1171.
Nathwani, D. and Zambrowski, J. J., on behalf of the AdHOC Workshop, 2000, Advisory group on home-based and outpatient care: An international consensus statement on non-inpatient parenteral therapy. Clin. Microbiol. Infect., 6(9), 464–476.
Pastel, D. A., Chang, S., Nessim, S., Shane, R., and Morgan, M. A., 1992, Department of pharmacy-initiated program for streamlining empirical antibiotic therapy. Hosp. Pharm., 27, 596–603, 614.
Prado, M. A., Lima, M. P., Gomes, I., and Bergsten-Mendes, G., 2002, The implementation of a surgical antibiotic prophylaxis program: The pivotal contribution of the hospital pharmacy. Am. J. Infect. Control, 30, 49–56.
Ramirez, J. A., 1996, Antibiotic streamlining: Development and justification of an antibiotic streamlining program. Pharm. Pract. Manag. Q., 16, 19–34.
Raynor, D. K., Sharp, J. A., Ratenbury, H., and Towler, R. J., 2000, Medicine Information Help Lines: A survey of hospital pharmacy-based services in the UK and their conformity with guidelines. Ann. Pharmcother., 34, 106–110.
Sanchez, D., Breland, B. D., Pinkos, L., Eagle, A., Nowlin, D., and Duty, L., 2003, Pharmacist-run influenza immunization clinic for health workers. Am. J. Health-Syst. Pharm., 60, 241–243.
Schentag, J. J., Ballow, C. H., Fritz, A. L., Paladino, J. A., Williams, J. D., Cumbo, T. J. et al., 1993, Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division and the microbiology laboratory. Diagn. Microbiol. Infect. Dis., 16, 255–264.
Schiff, G. D. and Rucker, T. D., 1998, Computerized prescribing. Building up electronic infrastructure for better medication usage. J. Am. Med. Assoc., 279, 1024–1029.
Shlaes, D. M., Gerding, D. N., John, J. E, Craig, W. A., Bornstein, D. L., Duncan, R. A. et al., 1997, Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals. Infect. Control Hosp. Epidemiol., 18, 275–291.
Swindell, P. J., Reeves, D. S., Bullock, D. W., Davies, A. J., and Spence, C. E., 1983, Audits of antibiotic prescribing in a Bristol hospital. Br. J. Med., 286, 118–122.
Van der Meer, J. W. and Gyssens, I. C., 2001, Quality of antimicrobial drug prescription in hospital. Clin. Microbiol. Infect., 7(Suppl 6), 12–15.
Watling, S. M., Harter, P. J., Lee, S. M., and Yanos, J., 1996, Multidisciplinary approach to improving antibiotic turnaround time in a medical intensive care unit. J. Pharm. Technol., 12, 280–283.
Williams, D. N., Rehm, S. J., Tice, A. D., Bradley, J. S., Kind, A. C., and Craig, W., 1997, Practice guidelines for community-based parenteral anti-infective therapy. Clin. Infect. Dis., 25, 787–801.
Working Party of the British Society for Antimicrobial Chemotherapy, Working Party Report, 1994, Hospital antibiotic control measures in the UK. J. Antimicrob. Chemother., 34, 21–42.
Wyllie, S., Weeks, C., Khachi, H., Vickers, M., and Jones, G., 2003, Letter to the editor. J. Hosp. Infect., 53, 85–90.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science + Business Media, Inc.
About this chapter
Cite this chapter
Knox, K., Lawson, W., Holmes, A. (2005). Multidisciplinary Antimicrobial Management Teams and the Role of the Pharmacist in Management of Infection. In: Gould, I.M., van der Meer, J.W.M. (eds) Antibiotic Policies. Springer, Boston, MA. https://doi.org/10.1007/0-387-22852-7_13
Download citation
DOI: https://doi.org/10.1007/0-387-22852-7_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-48500-8
Online ISBN: 978-0-387-22852-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)